126 related articles for article (PubMed ID: 17350258)
1. Lead optimization of methionine aminopeptidase-2 (MetAP2) inhibitors containing sulfonamides of 5,6-disubstituted anthranilic acids.
Wang GT; Mantei RA; Kawai M; Tedrow JS; Barnes DM; Wang J; Zhang Q; Lou P; Garcia LA; Bouska J; Yates M; Park C; Judge RA; Lesniewski R; Sheppard GS; Bell RL
Bioorg Med Chem Lett; 2007 May; 17(10):2817-22. PubMed ID: 17350258
[TBL] [Abstract][Full Text] [Related]
2. Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding.
Sheppard GS; Wang J; Kawai M; Fidanze SD; BaMaung NY; Erickson SA; Barnes DM; Tedrow JS; Kolaczkowski L; Vasudevan A; Park DC; Wang GT; Sanders WJ; Mantei RA; Palazzo F; Tucker-Garcia L; Lou P; Zhang Q; Park CH; Kim KH; Petros A; Olejniczak E; Nettesheim D; Hajduk P; Henkin J; Lesniewski R; Davidsen SK; Bell RL
J Med Chem; 2006 Jun; 49(13):3832-49. PubMed ID: 16789740
[TBL] [Abstract][Full Text] [Related]
3. QSAR study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using LS-SVM and GRNN based on principal components.
Shahlaei M; Sabet R; Ziari MB; Moeinifard B; Fassihi A; Karbakhsh R
Eur J Med Chem; 2010 Oct; 45(10):4499-508. PubMed ID: 20691509
[TBL] [Abstract][Full Text] [Related]
4. Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties.
Kawai M; BaMaung NY; Fidanze SD; Erickson SA; Tedrow JS; Sanders WJ; Vasudevan A; Park C; Hutchins C; Comess KM; Kalvin D; Wang J; Zhang Q; Lou P; Tucker-Garcia L; Bouska J; Bell RL; Lesniewski R; Henkin J; Sheppard GS
Bioorg Med Chem Lett; 2006 Jul; 16(13):3574-7. PubMed ID: 16632353
[TBL] [Abstract][Full Text] [Related]
5. Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates.
Levin JI; Chen JM; Cheung K; Cole D; Crago C; Santos ED; Du X; Khafizova G; MacEwan G; Niu C; Salaski EJ; Zask A; Cummons T; Sung A; Xu J; Zhang Y; Xu W; Ayral-Kaloustian S; Jin G; Cowling R; Barone D; Mohler KM; Black RA; Skotnicki JS
Bioorg Med Chem Lett; 2003 Aug; 13(16):2799-803. PubMed ID: 12873518
[TBL] [Abstract][Full Text] [Related]
6. 3-Amino-2-hydroxyamides and related compounds as inhibitors of methionine aminopeptidase-2.
Sheppard GS; Wang J; Kawai M; BaMaung NY; Craig RA; Erickson SA; Lynch L; Patel J; Yang F; Searle XB; Lou P; Park C; Kim KH; Henkin J; Lesniewski R
Bioorg Med Chem Lett; 2004 Feb; 14(4):865-8. PubMed ID: 15012983
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis inhibitors specific for methionine aminopeptidase 2 as drugs for malaria and leishmaniasis.
Zhang P; Nicholson DE; Bujnicki JM; Su X; Brendle JJ; Ferdig M; Kyle DE; Milhous WK; Chiang PK
J Biomed Sci; 2002; 9(1):34-40. PubMed ID: 11810023
[TBL] [Abstract][Full Text] [Related]
8. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 1: Structure-based design of novel acetylenic P1' groups.
Chen JM; Jin G; Sung A; Levin JI
Bioorg Med Chem Lett; 2002 Apr; 12(8):1195-8. PubMed ID: 11934587
[TBL] [Abstract][Full Text] [Related]
9. Anthranilate sulfonamide hydroxamate TACE inhibitors. Part 2: SAR of the acetylenic P1' group.
Levin JI; Chen JM; Du MT; Nelson FC; Killar LM; Skala S; Sung A; Jin G; Cowling R; Barone D; March CJ; Mohler KM; Black RA; Skotnicki JS
Bioorg Med Chem Lett; 2002 Apr; 12(8):1199-202. PubMed ID: 11934588
[TBL] [Abstract][Full Text] [Related]
10. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2.
Griffith EC; Su Z; Niwayama S; Ramsay CA; Chang YH; Liu JO
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15183-8. PubMed ID: 9860943
[TBL] [Abstract][Full Text] [Related]
11. The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position.
Levin JI; Du MT; DiJoseph JF; Killar LM; Sung A; Walter T; Sharr MA; Roth CE; Moy FJ; Powers R; Jin G; Cowling R; Skotnicki JS
Bioorg Med Chem Lett; 2001 Jan; 11(2):235-8. PubMed ID: 11206467
[TBL] [Abstract][Full Text] [Related]
12. The discovery of anthranilic acid-based MMP inhibitors. Part 2: SAR of the 5-position and P1(1) groups.
Levin JI; Chen J; Du M; Hogan M; Kincaid S; Nelson FC; Venkatesan AM; Wehr T; Zask A; DiJoseph J; Killar LM; Skala S; Sung A; Sharr M; Roth C; Jin G; Cowling R; Mohler KM; Black RA; March CJ; Skotnicki JS
Bioorg Med Chem Lett; 2001 Aug; 11(16):2189-92. PubMed ID: 11514167
[TBL] [Abstract][Full Text] [Related]
13. Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.
Marino JP; Fisher PW; Hofmann GA; Kirkpatrick RB; Janson CA; Johnson RK; Ma C; Mattern M; Meek TD; Ryan MD; Schulz C; Smith WW; Tew DG; Tomazek TA; Veber DF; Xiong WC; Yamamoto Y; Yamashita K; Yang G; Thompson SK
J Med Chem; 2007 Aug; 50(16):3777-85. PubMed ID: 17636946
[TBL] [Abstract][Full Text] [Related]
14. Correlation of tumor growth suppression and methionine aminopetidase-2 activity blockade using an orally active inhibitor.
Wang J; Tucker LA; Stavropoulos J; Zhang Q; Wang YC; Bukofzer G; Niquette A; Meulbroek JA; Barnes DM; Shen J; Bouska J; Donawho C; Sheppard GS; Bell RL
Proc Natl Acad Sci U S A; 2008 Feb; 105(6):1838-43. PubMed ID: 18252827
[TBL] [Abstract][Full Text] [Related]
15. Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2.
Arico-Muendel CC; Benjamin DR; Caiazzo TM; Centrella PA; Contonio BD; Cook CM; Doyle EG; Hannig G; Labenski MT; Searle LL; Lind K; Morgan BA; Olson G; Paradise CL; Self C; Skinner SR; Sluboski B; Svendsen JL; Thompson CD; Westlin W; White KF
J Med Chem; 2009 Dec; 52(24):8047-56. PubMed ID: 19929003
[TBL] [Abstract][Full Text] [Related]
16. 4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.
Kallander LS; Lu Q; Chen W; Tomaszek T; Yang G; Tew D; Meek TD; Hofmann GA; Schulz-Pritchard CK; Smith WW; Janson CA; Ryan MD; Zhang GF; Johanson KO; Kirkpatrick RB; Ho TF; Fisher PW; Mattern MR; Johnson RK; Hansbury MJ; Winkler JD; Ward KW; Veber DF; Thompson SK
J Med Chem; 2005 Sep; 48(18):5644-7. PubMed ID: 16134930
[TBL] [Abstract][Full Text] [Related]
17. Physiologically relevant metal cofactor for methionine aminopeptidase-2 is manganese.
Wang J; Sheppard GS; Lou P; Kawai M; Park C; Egan DA; Schneider A; Bouska J; Lesniewski R; Henkin J
Biochemistry; 2003 May; 42(17):5035-42. PubMed ID: 12718546
[TBL] [Abstract][Full Text] [Related]
18. Identification of potential inhibitors of human methionine aminopeptidase (type II) for cancer therapy: Structure-based virtual screening, ADMET prediction and molecular dynamics studies.
Weako J; Uba AI; Keskin Ö; Gürsoy A; Yelekçi K
Comput Biol Chem; 2020 Jun; 86():107244. PubMed ID: 32252002
[TBL] [Abstract][Full Text] [Related]
19. Identification of methionine aminopeptidase 2 as a molecular target of the organoselenium drug ebselen and its derivatives/analogues: Synthesis, inhibitory activity and molecular modeling study.
Węglarz-Tomczak E; Burda-Grabowska M; Giurg M; Mucha A
Bioorg Med Chem Lett; 2016 Nov; 26(21):5254-5259. PubMed ID: 27692546
[TBL] [Abstract][Full Text] [Related]
20. Methionine aminopeptidase 2 is a new target for the metastasis-associated protein, S100A4.
Endo H; Takenaga K; Kanno T; Satoh H; Mori S
J Biol Chem; 2002 Jul; 277(29):26396-402. PubMed ID: 11994292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
